Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,914.40
(
0.55%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.55
(
0.56%
)
Bitcoin
78,091.01
(
2.31%
)
News Focus
News Focus
Post# of 822366
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: dennisdave post# 705999

Sunday, 07/14/2024 4:24:38 PM

Sunday, July 14, 2024 4:24:38 PM

Post# of 822366

NWBO did adhere to the patient patient-level data. as set by the FDA.,,


Per the JAMA paper:

This study has limitations. Since individual patient-level data for the ECPs were not available for this trial, as is often the case, propensity score matching could not be performed, which is a potential limitation of this study.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News